Navigation Links
InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C
Date:5/29/2008

n combination with various direct antiviral compounds.

About InterMune

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and hepatology. InterMune has a pipeline portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The pulmonology portfolio includes the Phase 3 program, CAPACITY, which is evaluating pirfenidone as a possible therapeutic candidate for the treatment of patients with IPF and a research program focused on small molecules for pulmonary disease. The hepatology portfolio includes the HCV protease inhibitor compound ITMN-191 (referred to as R7227 at Roche) in Phase 1b, a second-generation HCV protease inhibitor research program, and a research program evaluating a new target in hepatology. For additional information about InterMune and its R&D pipeline, please visit http://www.intermune.com.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of section 21E of the Securities Exchange Act of 1934, as amended, that reflect InterMune's judgment and involve risks and uncertainties as of the date of this release, including without limitation the statements related to anticipated product development timelines. All forward-looking statements and other information included in this press release are based on information available to InterMune as of the date hereof, and InterMune assumes no obligation to update any such forward-looking statements or information. InterMune's actual results could differ materially from those described in InterMune's forward-looking statements.

Factors that could cause or contribute to such differences include, but are not limited to, those discussed in detail under the heading "Risk Factors" in InterMune's most recent annual report on Form 10-K filed with the SEC on March 14,
'/>"/>

SOURCE InterMune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
2. InterMune Announces Start of Phase 1b Trial of ITMN-191
3. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
4. InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
5. InterMune Announces Progress on Pirfenidone in IPF
6. InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... ,, NEWYORK,Nov.25/PRNewswire/--Reportlinker...leinitscatalogue: ,, IntranasalDrugDelivery-US....com/p0164267/Intranasal-Drug-Delivery---US-Market...eliverymarketiswitnessinganexpansionoftherapeutica...peuticdrugstothedeliveryofsystemictherapeuticdrugs...
(Date:11/24/2009)... ,, BETHESDA,Md.,Nov.24/PRNewswire-Asia/--Ch...,aleadingindependentAmericanproviderofWestern,heal...ina,today,announcedthattheCompanywillattendthe21st...,tobeheldDecember1-2,2009,atthe,NewYorkPalaceHotel...11:30amETonTuesday,December1,2009,andholdone-on-o...
(Date:11/24/2009)... ,, FREMONT,Calif.,Nov.24/PRNewswire-FirstCa...cedtheCompanyfileditsPlanofReorganizationandDisclo...atesBankruptcyCourtfortheDistrictofDelaware.Aheari...entlyscheduledforDecember8,2009,withthehearingonth..., ThePlancallsfortheCompanytopayallclaimsinfull...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Chindex International to Present at Piper Jaffray Health Care Conference 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Hodgkin lymphoma survivors have increased risk of stroke and transient ischemic attack 49305 1Hodgkin lymphoma survivors have increased risk of stroke and transient ischemic attack 49305 2Beaked bird like dinosaur tells story of finger evolution 8887 1Beaked bird like dinosaur tells story of finger evolution 8887 2HealthTronics Inc Commences Exchange Offer for Endocare Inc Shares 49298 1HealthTronics Inc Commences Exchange Offer for Endocare Inc Shares 49298 2HealthTronics Inc Commences Exchange Offer for Endocare Inc Shares 49298 3
(Date:11/25/2009)...,Minn.,Nov.25/PRNewswire-USNewswire/--Whenmostpeop...iropractorcanalsogivepatientsthehelptheyneed.TMJst...rjaw(mandible)contacts/connectswithyourskull(tempo...hTMJdysfunctionarepainwithchewing,clickingorpoppin...sfunctionincluding:headaches,fatigue,sleepdisturba...
(Date:11/25/2009)...TO,Nov.25/PRNewswire/-SentinelleMedicalInc.,aleadi...tionsoftwarelaunchesasuiteofnewleadingedgeclinical...atformatthisyear,sRadiologicalSocietyofNorthAmeric...oth5800,HallA).Theapplicationsleveragetheuniquehig...Iimagingcoilsandsupportmultipleimagingmodalitiesfo...
(Date:11/25/2009)...ANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQualityMa... Spare the Air Alert forThursday,Novem...soranyothersolidfuel,bothindoorsandoutdoors. ,,...litytomorrow,"saidJackBroadbent,executiveofficerof...ctthehealthoftheirneighborsandfellowcommunitymembe...
(Date:11/25/2009)...ous discovery that grew out of a collaboration bet...ly offer hope to the nearly 10 million Americans w... Also known as hardening of the arteries, periphe...ory problem in which narrowed arteries reduce bloo... red flag for vascular disease, heart attack and s...
(Date:11/25/2009)... Evaluation and treatment clinics to r...oodstock (Vocus) November 25, 2009 -- Centegra Hea...nes and H1N1 vaccine shots at four Centegra Primar...pment of vaccine has arrived. The clinics are at C...cHenry and will be open as follows: ,   ...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
... Exposure to estrogens in the early stages of the ...s is a factor cited by the scientists for the deve...f life. // The study, done in an animal mode... of estrogens (xenoestrogens) are widespread in th...
... Students of Delhi University will soon be evaluat...cademic reform measures being introduced. // ...ancellor earlier this year, the academic reform co... top priorities for the committee and we want to m...
... Medical services in state-run hospitals across th...to work after 20 days of anti-quota protests follo...OPD services in premier health institutions like A...government hospitals in West Bengal, Karnataka, Ut...
... With the medicos' agitation against reservation c... withdraw it // , the casualty ward of the MKCG Me... a group of people who alleged that negligence cau... 'We brought him to the hospital immediately af...
... India and Singapore have agreed to cooperate in s...ism, //money laundering, organized crime and drugs...agement. "The two sides decided to cooperate ...ment," a senior official told PTI Wednesday here. ...
... New Delhi. Taking serious note of the plight of ... protesting medicos to call off their strike //for...tive action against them. Observing that the...orm of dissent. "Whatever Government does is ...
Other Medicine News:Health News:Prostate Cancer Risk Linked To Early Estrogen Exposure 2Health News:Students to Evaluate the Performance of Teachers 2
Slimtine S
M 3.2 J Unipolar Atrial "J" Lead
VascoTip P 9/60 PU S
VascoTip P 9/60 M
Medicine Products: